サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1592691

プロテインシーケンシング市場- 世界および地域別分析：製品・サービス別、用途別、試料タイプ別、投入試料の複雑さと読み出しの複雑さ別、技術別、エンドユーザー別、地域別 - 分析と予測（2024年～2033年）

Protein Sequencing Market - A Global and Regional Analysis: Focus on Product, Technology, Application, End User, and Region - Analysis and Forecast, 2024-2033

出版日
発行
BIS Research
ページ情報
英文 136 Pages
納期
1～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
プロテインシーケンシング市場- 世界および地域別分析：製品・サービス別、用途別、試料タイプ別、投入試料の複雑さと読み出しの複雑さ別、技術別、エンドユーザー別、地域別 - 分析と予測（2024年～2033年）
出版日: 2024年11月19日
発行: BIS Research
ページ情報: 英文 136 Pages
納期: 1～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

プロテインシーケンシングとは、タンパク質中のアミノ酸の正確な順序を決定するプロセスであり、タンパク質の構造、機能、および生体システムにおける役割を理解する上で極めて重要です。

バイオテクノロジー、生物医学研究、創薬、疾病診断などの分野で重要な役割を果たしています。プロテインシーケンスにより、翻訳後修飾、タンパク質相互作用、疾患メカニズムに関する貴重な洞察が得られ、精密医療や標的治療の進歩が可能になります。

プロテインシーケンシングの2つの主要な技術は、エドマン分解と質量分析です。エドマン分解は小さなタンパク質に使用され、アミノ酸を順次除去します。一方、質量分析は高いスループットと複雑なサンプルの分析能力により、大規模プロテオミクスに広く使用されています。さらに、この市場は、機器、試薬、シーケンスプロセスを促進する消耗品、および様々な産業向けにプロテインシーケンスサービスを提供する受託研究機関から構成されています。バイオマーカー探索と医薬品開発に対する需要の高まりが、この分野の技術革新を引き続き後押ししています。

主要市場統計
予測期間 2024年～2033年
2024年評価 18億3,630万米ドル
2033年予測 26億9,700万米ドル
CAGR 4.36%

2023年に当初17億4,900万米ドルと評価された世界のプロテインシーケンシング市場は、2033年には26億9,700万米ドルに達し、CAGR4.36%と著しい伸びを示すと予測され、大幅な成長が見込まれています。個別化医療が重視されるようになったことが、プロテインシーケンスの大きな推進力となっています。タンパク質の正確なアミノ酸配列と修飾を理解することは、バイオマーカーを特定し、がん、神経変性疾患、心血管疾患などの疾患に対する標的療法を開発する上で極めて重要です。プロテインシーケンシングは創薬においても不可欠であり、タンパク質構造の詳細な知識により、創薬ターゲットとなりうるタンパク質の同定が可能になります。バイオ医薬品企業は、モノクローナル抗体や治療用タンパク質などの生物製剤の開発にシーケンスデータを活用しています。

技術の進歩によりプロテインシーケンスの精度とアクセシビリティが向上し続ける中、この市場はヘルスケア提供に革命をもたらし、予防医療と個別化医療の時代を世界規模で切り開く原動力となっています。

この市場の製品には、質量分析計やシーケンスなどの機器、タンパク質の調製、消化、分析に不可欠な試薬や消耗品などが含まれます。これらのツールは、研究者が正確でハイスループットのプロテインシーケンシングを行うために不可欠です。さらに、受託研究機関やその他のサービスプロバイダーは、バイオ製薬会社、学術機関、研究所にプロテインシーケンスサービスを提供する上で重要な役割を果たしています。これらのサービスには、タンパク質の同定から複雑な翻訳後修飾の解析まで、あらゆるものが含まれます。バイオマーカー探索、個別化医療、バイオ医薬品における用途の拡大に伴い、プロテインシーケンス市場の製品およびサービスに対する需要は、特に北米やアジア太平洋などの地域で増加しています。

当レポートでは、世界のプロテインシーケンシング市場について調査し、市場の概要とともに、製品・サービス別、用途別、試料タイプ別、投入試料の複雑さと読み出しの複雑さ別、技術別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 世界のプロテインシーケンシング市場：概要

  • 動向：現在および将来の影響評価
  • プロテインシーケンシングのワークフロー
  • 規制の枠組み
  • 特許分析
  • 市場力学の概要

第2章 世界のプロテインシーケンシング市場（製品・サービス別）、100万米ドル、2022年～2033年

  • 製品
  • サービス

第3章 世界のプロテインシーケンシング市場（用途別）、100万米ドル、2022年～2033年

  • バイオ医薬品
  • 遺伝子工学
  • その他

第4章 世界のプロテインシーケンシング市場（試料タイプ別）、100万米ドル、2022年～2033年

  • 生体試料
  • 組織試料
  • 培養細胞
  • その他

第5章 世界のプロテインシーケンシング市場（投入試料の複雑さと読み出しの複雑さ別）、100万米ドル、2022年～2033年

  • 投入試料の複雑さ
  • 読み出しの複雑さ

第6章 世界のプロテインシーケンシング市場（技術別）、100万米ドル、2022年～2033年

  • 質量分析
  • エドマン劣化
  • その他（一分子タンパク質配列解析など）

第7章 世界のプロテインシーケンシング市場（エンドユーザー別）、100万米ドル、2022年～2033年

  • 学術機関および研究センター
  • 製薬およびCRO
  • バイオテクノロジー、診断、その他の企業

第8章 世界のプロテインシーケンシング市場（地域別）、100万米ドル、2022年～2033年

  • 地域別概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他

第9章 市場-競合情勢

  • 世界のプロテインシーケンシング市場：競合情勢
  • 事業戦略：2021年1月～2024年9月
  • 企業プロファイル
    • Agilent Technologies, Inc.
    • Bioinformatics Solutions Inc.
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Charles River Laboratories International, Inc.
    • Creative Proteomics
    • FUJIFILM Holdings Corporation
    • Merck KGaA
    • Proteome Factory AG
    • Rapid Novor, Inc.
    • Seer, Inc.
    • Selvita S.A.
    • Shimadzu Corporation
    • Thermo Fisher Scientific, Inc.

第10章 調査手法

図表

List of Figures

  • Figure 1: Global Protein Sequencing Market, $Million, 2024, 2028, and 2033
  • Figure 2: Global Protein Sequencing Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Global Protein Sequencing Market (by Product and Service), $Million, 2023, 2027, and 2033
  • Figure 4: Global Protein Sequencing Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 5: Global Protein Sequencing Market (by Technology), $Million, 2023, 2027, and 2033
  • Figure 6: Global Protein Sequencing Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 7: Key Events to Keep Track of in the Protein Sequencing Market
  • Figure 8: Protein Sequencing Workflow Overview
  • Figure 9: Number of Protein Sequencing Patents (by Country), January 2019-May 2024
  • Figure 10: Number of Protein Sequencing Patents (by Year), January 2019-May 2024
  • Figure 11: Impact Analysis of Market Navigating Factors, 2022-2033
  • Figure 12: Pipeline Involved in Protein Sequencing using Tandem Mass Spectrometry
  • Figure 13: Edman Degradation Protein Sequencing Workflow
  • Figure 14: Proteomics Literature Published in the U.S. (January 2020 to September 2024)
  • Figure 15: U.S. Protein Sequencing Market, $Million, 2022-2033
  • Figure 16: Canada Protein Sequencing Market, $Million, 2022-2033
  • Figure 17: Germany Protein Sequencing Market, $Million, 2022-2033
  • Figure 18: U.K. Protein Sequencing Market, $Million, 2022-2033
  • Figure 19: France Protein Sequencing Market, $Million, 2022-2033
  • Figure 20: Italy Protein Sequencing Market, $Million, 2022-2033
  • Figure 21: Spain Protein Sequencing Market, $Million, 2022-2023
  • Figure 22: Rest-of-Europe Protein Sequencing Market, $Million, 2022-2033
  • Figure 23: China Protein Sequencing Market, $Million, 2022-2033
  • Figure 24: Japan Protein Sequencing Market, $Million, 2022-2033
  • Figure 25: India Protein Sequencing Market, $Million, 2022-2033
  • Figure 26: Australia Protein Sequencing Market, 2022-2033
  • Figure 27: South Korea Protein Sequencing Market, $Million, 2022-2033
  • Figure 28: Rest-of-Asia-Pacific Protein Sequencing Market, $Million, 2022-2033
  • Figure 29: Brazil Protein Sequencing Market, $Million, 2022-2033
  • Figure 30: Mexico Protein Sequencing Market, $Million, 2022-2033
  • Figure 31: Rest-of-Latin America Protein Sequencing Market, $Million, 2022-2033
  • Figure 32: Corporate Strategies, January 2021- September 2024
  • Figure 33: Acquisitions (by Company), January 2021-September 2024
  • Figure 34: Funding Activities Share (by Company), January 2021-September 2024
  • Figure 35: Product Launches (by Company), January 2021-September 2024
  • Figure 36: Data Triangulation
  • Figure 37: Top-Down and Bottom-Up Approach
  • Figure 38: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Protein Sequencing Market Opportunities
  • Table 3: Product Launches, January 2023-September 2024
  • Table 4: Companies Providing Single-Molecule Protein Sequencing
  • Table 5: List of Molecular Targets Identified with Proteomics
  • Table 6: Major Protein Sequencing and Mass Spectrometry Service Fee
  • Table 7: Global Protein Sequencing Market (by Product and Service), $Million, 2022-2033
  • Table 8: Global Protein Sequencing Market, (by Product Type), $Million, 2022-2033
  • Table 9: Global Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 10: Global Protein Sequencing Market (by Sample Type), $Million, 2022-2033
  • Table 11: Global Protein Sequencing Market (by Input Sample Complexity), $Million, 2022-2033
  • Table 12: Global Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 13: Global Single Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 14: Global Multiplex Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 15: Global Highly Complex Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 16: Global Protein Sequencing Market (by Technology), $Million, 2022-2033
  • Table 17: Global Mass Spectrometry Protein Sequencing Market (by Input Sample Complexity), $Million, 2022-2033
  • Table 18: Global Mass Spectrometry Protein Sequencing Market (by Readout Complexity), $Million, 2022-2033
  • Table 19: Global Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 20: North America Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 21: North America Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 22: Europe Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 23: Europe Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 24: Asia-Pacific Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 25: Asia-Pacific Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 26: Latin America Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 27: Latin America Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 28: Rest-of-the-World Protein Sequencing Market (by End User), $Million, 2022-2033
  • Table 29: Rest-of-the-World Protein Sequencing Market (by Application), $Million, 2022-2033
  • Table 30: Partnerships, Alliances, and Business Expansions (by Company), January 2021-September 2024
目次
Product Code: BHP1627SA

Introduction to Protein Sequencing

Protein sequencing is the process of determining the precise order of amino acids in a protein, which is crucial for understanding its structure, function, and role in biological systems. It plays an essential role in fields such as biotechnology, biomedical research, drug discovery, and disease diagnostics. Protein sequencing provides valuable insights into post-translational modifications, protein interactions, and disease mechanisms, enabling advancements in precision medicine and targeted therapies.

The two primary techniques for protein sequencing are Edman degradation and mass spectrometry. Edman degradation is used for smaller proteins, sequentially removing amino acids, while mass spectrometry is widely used for large-scale proteomics due to its high throughput and ability to analyze complex samples. Additionally, the market consists of instruments, reagents, consumables that facilitate the sequencing process, and contract research organizations providing protein sequencing services for various industries. The growing demand for biomarker discovery and drug development continues to drive innovations in this space.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$1,836.3 Million
2033 Forecast$2,697.0 Million
CAGR4.36%

Market Introduction

The global protein sequencing market, initially valued at $1,749.0 million in 2023, is poised for substantial growth, projected to reach $2,697.0 million by 2033, marking a remarkable compound annual growth rate (CAGR) of 4.36%. The growing emphasis on personalized medicine is a major driver for protein sequencing. Understanding the precise amino acid sequence and modifications of proteins is crucial for identifying biomarkers and developing targeted therapies for diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions. Protein sequencing is also essential in drug discovery, where detailed knowledge of protein structures enables the identification of potential drug targets. Biopharmaceutical companies rely on sequencing data to develop biologics, such as monoclonal antibodies and therapeutic proteins.

As advancements in technology continue to enhance the accuracy and accessibility of protein sequencing, the market is primed to revolutionize healthcare delivery, ushering in an era of preventive and personalized medicine on a global scale.

Products in this market include instruments such as mass spectrometers and sequence and reagents and consumables essential for protein preparation, digestion, and analysis. These tools are vital for researchers to conduct precise, high-throughput protein sequencing. Additionally, contract research organizations and other service providers play a crucial role in offering protein sequencing services to biopharmaceutical companies, academic institutions, and research labs. These services encompass everything from protein identification to complex post-translational modification analysis. With growing applications in biomarker discovery, personalized medicine, and biopharmaceuticals, the demand for products and services in the protein sequencing market has been increasing, particularly in regions such as North America and Asia-Pacific.

Industrial Impact

The industrial impact of the protein sequencing market has been profound, significantly influencing various sectors, including healthcare, pharmaceuticals, biotechnology, and research. In the healthcare industry, protein sequencing enables the identification of biomarkers for early disease detection, leading to more precise diagnostics. It supports the development of personalized medicine, allowing for tailored treatments based on a patient's unique protein expression profile. In the manufacturing of biologics, ensuring protein integrity and sequence consistency is critical for maintaining product quality. Protein sequencing is used extensively in process optimization and quality control to monitor the purity and structural fidelity of proteins used in biopharmaceutical production. Moreover, the increasing use of sequencing in academic and clinical research has been driving scientific discoveries and expanding one's understanding of diseases and human biology. Overall, the integration of protein sequencing across these industries has fostered innovation, improved efficiency, and opened new avenues for economic growth and development. The integration of novel sequencing technologies and mass spectrometry has enhanced the scalability and precision of protein sequencing, increasing its industrial application across multiple sectors.

Market Segmentation

Segmentation 1: By Product and Service

  • Product
  • Service

Product Segment to Lead the Global Protein Sequencing Market (by Product and Service)

In the global protein sequencing market, as of 2023, the product segment held the largest share at 72.37%. This dominance can be attributed to the essential role of products such as mass spectrometry instruments and sample preparation reagents in the sequencing process.

Segmentation 2: By Application

  • Biotherapeutics
  • Genetic Engineering
  • Others

Biotherapeutics to Witness the Highest Growth between 2024 and 2033

Based on application, the global protein market was led by the biotherapeutics segment, which held a 69.51% share in 2023. Protein sequencing is crucial in developing and manufacturing biotherapeutics, including monoclonal antibodies, therapeutic proteins, and vaccines. Sequencing is essential for understanding protein structure, ensuring safety and efficacy, and optimizing manufacturing processes. This application area has been witnessing significant growth due to the rise of precision medicine and the increasing demand for targeted therapies in chronic diseases such as cancer, autoimmune disorders, and genetic conditions. The global burden of chronic diseases, particularly cancer, diabetes, and autoimmune diseases, has been pushing the demand for biotherapeutics, where protein sequencing plays a key role in the discovery and development of novel treatments.

Segmentation 3: By Sample Type

  • Biological Sample
  • Tissue Sample
  • Cultured Cell
  • Other Samples

Biological Samples Segment to Witness the Highest Growth between 2024 and 2033

Biological samples, which include a wide range of samples from living organisms (such as blood, urine, and saliva), are essential for various applications, including clinical diagnostics, drug development, and personalized medicine. The increasing demand for targeted therapies and personalized healthcare has been driving the growth of this segment. The development of advanced protein sequencing technologies, such as mass spectrometry and next-generation protein sequencing (NGS), has made it easier and more cost-effective to analyze biological samples in the near future.

Segmentation 4: By Technology

  • Mass Spectrometry
  • Edman Degradation
  • Other Technologies

Mass Spectrometry Segment to Occupy the Major Market Share between 2024 and 2033

In the protein sequencing market, the mass spectrometry segment will occupy the major market share between 2024 and 2033. Nevertheless, as next-generation sequencing technologies become more established and integrated into research workflows, they will shift market dynamics. Nanopore sequencing enables real-time sequencing of proteins and is particularly appealing due to its ability to provide long-read sequencing capabilities. Although still emerging, nanopore technology will enhance protein sequencing by providing insights into protein structure and interactions that mass spectrometry may not fully capture. This will also lead to increased collaboration and the development of hybrid approaches that leverage the strengths of both sequencing and mass spectrometry.

Segmentation 5: By End User

  • Academic Institutes
  • Pharma and CROs
  • Biotech, Diagnostics, and Other Companies

Academic Institutes Segment to Hold the Major Market Share between 2024 and 2033

In the global protein sequencing market, as of 2023, the academic institute segment held the largest share at 47.30%. The growth of the protein sequencing market has been fueled by rising investments in proteomics research. For example, Thermo Fisher's Quantitative Proteomics Research Grant Program provides up to $11,000 in mass spectrometry reagents to doctoral and post-doctoral students, promoting innovative research in quantitative proteomics. This initiative highlights private-sector support for academic research. Moreover, collaborations between academic institutions and biotech companies have been driving technological advancements, enhancing research capabilities, and broadening the market.

Segmentation 6: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Rest-of-the-World

The protein sequencing market in the North America region is expected to witness a significant growth rate of 3.81% during the forecast period, marked by the increasing demand for preventative medicine, clinical diagnostics, drug development, and biomarker discovery. However, the Asia-Pacific region is expected to reach $623.5 million in 2033 from $348.4 million in 2023, at a CAGR of 5.93% during the forecast period 2024-2033.

Recent Developments in the Protein Sequencing Market

  • In September 2024, GenNext Technologies and Agilent announced a collaboration for structural biology research for biopharmaceutical companies. The integration of GenNext's AutoFox Protein Footprinting System with Agilent's 6560 Ion Mobility Quadrupole Time-of-Flight Liquid Chromatography/Mass Spectrometry system is to be used for detailed protein structure analysis and biomolecular interaction studies.
  • In July 2024, Agilent acquired Sigsense, a company that developed AI-enabled lab operations technology assisting in enhancing and optimizing laboratory workflows.
  • In July 2024, Bioinformatics Solutions Inc. announced the release of PEAKS Studio 12 as part of the PEAKS 12 software generation. Leveraging the latest mass spectrometry technology, the offering advances research with proteomics solutions employing deep learning and innovative algorithms that support data analysis for peptide and protein identification and quantification.
  • In June 2024, Agilent announced advancements in GC/MS and LC/Q-TOF technology at the American Society for Mass Spectrometry 2024. The new HES 2.0 ion source provides atto-gram-level sensitivity along with a built-in intelligence system to streamline workflows.
  • In June 2024, Thermo Fisher Scientific introduced the Thermo Scientific Stellar mass spectrometer to advance clinical research.

Demand - Drivers, Challenges, and Opportunities

Market Demand Drivers:

Advancements in Computational Biology and Bioinformatics: Recent advancements in computational biology and bioinformatics have significantly influenced the protein sequencing market, particularly in drug discovery, proteomics research, and biomarker identification. These technologies utilize sophisticated algorithms, simulations, and extensive biological datasets to improve the design and analysis of protein sequences, thereby enhancing the accuracy and efficiency of sequencing methods.

Market Challenges:

Shortage of Skilled Labor: The protein sequencing process entails complex procedures that require a comprehensive understanding of biochemistry, molecular biology, and advanced analytical techniques. Skilled professionals are essential to operate sophisticated instruments, such as mass spectrometers, to ensure accurate and reliable data acquisition. Moreover, these experts must possess strong computational and bioinformatics capabilities to manage and interpret the substantial volumes of data generated during sequencing.

Market Opportunities:

Integration of Artificial Intelligence: The integration of artificial intelligence, particularly machine learning algorithms such as XGBoost, with protein sequencing technologies presents a significant opportunity to transform the field of molecular diagnostics and therapeutic decision-making. By employing novel materials, such as solid-state 2D phosphorene nanoslit devices, AI-enhanced models can significantly improve the accuracy and speed of amino acid identification at the single-molecule level, addressing long-standing challenges in high-throughput protein sequencing.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in protein sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2020-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2033.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of upstream and downstream products of protein.
  • The market contribution of the protein technologies anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
  • The company's revenue has been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available protein sequencing solutions. This report has considered and profiled all the key companies with significant offerings in this field.

Primary Research:

The primary sources involve industry experts in protein, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

The global protein sequencing market is driven by a diverse group of key players, each leveraging advanced technologies to meet the growing demand for accurate, high-throughput protein analysis. Some of the key players, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories provide cutting-edge sequencing platforms, reagents and software. Further, the market also includes the presence of various service providers, such as Charles River Laboratories International, Inc. and Creative Proteomics, which have established a competitive advantage by offering tailored protein sequencing solutions, ranging from protein characterization to post-translational modifications.

Some prominent names established in this market are:

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific, Inc.
  • Shimadzu Corporation
  • Charles River Laboratories
  • Selvita
  • Bruker Corporation
  • Merck KGaA
  • Seer, Inc.
  • FUJIFILM Holdings Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Global Protein Sequencing Market: Overview

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Product Launches in the Market
    • 1.1.2 Growing Adoption of Single-Molecule Protein Sequencing
    • 1.1.3 High Demand for Biologics Development
  • 1.2 Workflow of Protein Sequencing
    • 1.2.1 Protein Sequencing Workflow Overview
  • 1.3 Regulatory Framework
    • 1.3.1 U.S.
      • 1.3.1.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.1.2 Regulatory Requirements for Research Use Only (RUO) Products
      • 1.3.1.3 Requirements under the Clinical Laboratory Improvement Amendments (CLIA) for Clinical Protein Sequencing Labs
    • 1.3.2 European Union (EU)
      • 1.3.2.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
        • 1.3.2.1.1 EU Medical Device Regulation
        • 1.3.2.1.2 EU In Vitro Diagnostic Regulation
      • 1.3.2.2 Regulatory Requirements for Clinical Protein Sequencing Labs in the EU
    • 1.3.3 Japan
      • 1.3.3.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.3.2 Regulatory Requirements for Clinical Protein Sequencing Labs in Japan
    • 1.3.4 China
      • 1.3.4.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
    • 1.3.5 Brazil
      • 1.3.5.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.5.2 Regulatory Requirements for Clinical Protein Sequencing Labs in Brazil
  • 1.4 Patent Analysis
    • 1.4.1 Patent Filing Trend (by Country)
    • 1.4.2 Patent Filing Trend (by Year)
  • 1.5 Market Dynamics Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Advancements in Computational Biology and Bioinformatics in the Global Protein Engineering Market
      • 1.5.1.2 Expanding Applications in Research
      • 1.5.1.3 Technological Advancements in Protein Sequencing
    • 1.5.2 Market Restraints
      • 1.5.2.1 Shortage of Skilled Labour
      • 1.5.2.2 High Cost Hindering the Adoption of Protein Sequencing
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Integration of Artificial Intelligence in Protein Sequencing

2 Global Protein Sequencing Market (by Product and Service), $Million, 2022-2033

  • 2.1 Product
    • 2.1.1 Instruments
    • 2.1.2 Reagents and Consumables
  • 2.2 Service

3 Global Protein Sequencing Market (by Application), $Million, 2022-2033

  • 3.1 Biotherapeutics
  • 3.2 Genetic Engineering
  • 3.3 Others

4 Global Protein Sequencing Market (by Sample Type), $Million, 2022-2033

  • 4.1 Biological Sample
  • 4.2 Tissue Sample
  • 4.3 Cultured Cell
  • 4.4 Other Samples

5 Global Protein Sequencing Market (by Input Sample Complexity and Readout Complexity), $Million, 2022-2033

  • 5.1 Input Sample Complexity
    • 5.1.1 Single Purified Proteins
    • 5.1.2 Multiplex Proteins
    • 5.1.3 Highly Complex Proteins
  • 5.2 Readout Complexity
    • 5.2.1 Simple Presence/Absence
    • 5.2.2 Expression Level
    • 5.2.3 Post-Translational Modifications (PTMs)
    • 5.2.4 Full Protein Sequence

6 Global Protein Sequencing Market (by Technology), $Million, 2022-2033

  • 6.1 Mass Spectrometry
  • 6.2 Edman Degradation
  • 6.3 Other Technologies (Single-Molecule Protein Sequencing and Others)

7 Global Protein Sequencing Market (by End User), $Million, 2022-2033

  • 7.1 Academic Institutes and Research Centers
  • 7.2 Pharmaceutical and CROs
  • 7.3 Biotechnology, Diagnostic, and Other Companies

8 Global Protein Sequencing Market (By Region), $Million, 2022-2033

  • 8.1 Regional Summary
  • 8.2 North America
    • 8.2.1 Regional Overview
    • 8.2.2 Driving Factors for Market Growth
    • 8.2.3 Factors Challenging the Market
    • 8.2.4 U.S.
    • 8.2.5 Canada
  • 8.3 Europe
    • 8.3.1 Regional Overview
    • 8.3.2 Driving Factors for Market Growth
    • 8.3.3 Factors Challenging the Market
    • 8.3.4 Germany
    • 8.3.5 U.K.
    • 8.3.6 France
    • 8.3.7 Italy
    • 8.3.8 Spain
    • 8.3.9 Rest-of-Europe
  • 8.4 Asia-Pacific
    • 8.4.1 Regional Overview
    • 8.4.2 Driving Factors for Market Growth
    • 8.4.3 Factors Challenging the Market
    • 8.4.4 China
    • 8.4.5 Japan
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 South Korea
    • 8.4.9 Rest-of-Asia-Pacific
  • 8.5 Latin America
    • 8.5.1 Regional Overview
    • 8.5.2 Driving Factors for Market Growth
    • 8.5.3 Factors Challenging the Market
    • 8.5.4 Brazil
    • 8.5.5 Mexico
    • 8.5.6 Rest-of-Latin America
  • 8.6 Rest-of-the-World Protein Sequencing Market
    • 8.6.1 Regional Overview
    • 8.6.2 Driving Factors for Market Growth
    • 8.6.3 Factors Challenging the Market

9 Markets - Competitive Landscape

  • 9.1 Global Protein Sequencing Market: Competitive Landscape
    • 9.1.1 Corporate Strategies, January 2021-September 2024
    • 9.1.2 Partnerships, Alliances, and Business Expansions
    • 9.1.3 Mergers and Acquisitions
    • 9.1.4 Funding Activities
  • 9.2 Business Strategies, January 2021-September 2024
    • 9.2.1 Service/Product Launches
  • 9.3 Company Profiles
    • 9.3.1 Agilent Technologies, Inc.
      • 9.3.1.1 Overview
      • 9.3.1.2 Top Products
      • 9.3.1.3 Top Competitors
      • 9.3.1.4 Target Customers/End Users
      • 9.3.1.5 Analyst View
    • 9.3.2 Bioinformatics Solutions Inc.
      • 9.3.2.1 Overview
      • 9.3.2.2 Services Offered
      • 9.3.2.3 Top Competitors
      • 9.3.2.4 Target Customers/End Users
      • 9.3.2.5 Analyst View
    • 9.3.3 Bio-Rad Laboratories, Inc.
      • 9.3.3.1 Overview
      • 9.3.3.2 Top Products
      • 9.3.3.3 Top Competitors
      • 9.3.3.4 Target Customers/End Users
      • 9.3.3.5 Analyst View
    • 9.3.4 Bruker Corporation
      • 9.3.4.1 Overview
      • 9.3.4.2 Top Products
      • 9.3.4.3 Top Competitors
      • 9.3.4.4 Target Customers/End Users
      • 9.3.4.5 Analyst View
    • 9.3.5 Charles River Laboratories International, Inc.
      • 9.3.5.1 Overview
      • 9.3.5.2 Services Offered
      • 9.3.5.3 Top Competitors
      • 9.3.5.4 Target Customers/End Users
      • 9.3.5.5 Analyst View
    • 9.3.6 Creative Proteomics
      • 9.3.6.1 Overview
      • 9.3.6.2 Services Offered
      • 9.3.6.3 Top Competitors
      • 9.3.6.4 Target Customers/End Users
      • 9.3.6.5 Analyst View
    • 9.3.7 FUJIFILM Holdings Corporation
      • 9.3.7.1 Overview
      • 9.3.7.2 Top Products
      • 9.3.7.3 Top Competitors
      • 9.3.7.4 Target Customers/End Users
      • 9.3.7.5 Analyst View
    • 9.3.8 Merck KGaA
      • 9.3.8.1 Overview
      • 9.3.8.2 Top Products
      • 9.3.8.3 Top Competitors
      • 9.3.8.4 Target Customers/End Users
      • 9.3.8.5 Analyst View
    • 9.3.9 Proteome Factory AG
      • 9.3.9.1 Overview
      • 9.3.9.2 Services Offered
      • 9.3.9.3 Top Competitors
      • 9.3.9.4 Target Customers/End Users
      • 9.3.9.5 Analyst View
    • 9.3.10 Rapid Novor, Inc.
      • 9.3.10.1 Overview
      • 9.3.10.2 Services Offered
      • 9.3.10.3 Top Competitors
      • 9.3.10.4 Target Customers/End Users
      • 9.3.10.5 Analyst View
    • 9.3.11 Seer, Inc.
      • 9.3.11.1 Overview
      • 9.3.11.2 Top Products
      • 9.3.11.3 Top Competitors
      • 9.3.11.4 Target Customers/End Users
      • 9.3.11.5 Analyst View
    • 9.3.12 Selvita S.A.
      • 9.3.12.1 Overview
      • 9.3.12.2 Services Offered
      • 9.3.12.3 Top Competitors
      • 9.3.12.4 Target Customers/End Users
      • 9.3.12.5 Analyst View
    • 9.3.13 Shimadzu Corporation
      • 9.3.13.1 Overview
      • 9.3.13.2 Top Products
      • 9.3.13.3 Top Competitors
      • 9.3.13.4 Target Customers/End Users
      • 9.3.13.5 Analyst View
    • 9.3.14 Thermo Fisher Scientific, Inc.
      • 9.3.14.1 Overview
      • 9.3.14.2 Top Products
      • 9.3.14.3 Top Competitors
      • 9.3.14.4 Target Customers/End Users
      • 9.3.14.5 Analyst View

10 Research Methodology

  • 10.1 Data Sources
    • 10.1.1 Primary Data Sources
    • 10.1.2 Secondary Data Sources
    • 10.1.3 Data Triangulation
  • 10.2 Market Estimation and Forecast